Á lódáil...
Trial watch: Tumor-targeting monoclonal antibodies for oncological indications
An expanding panel of monoclonal antibodies (mAbs) that specifically target malignant cells or intercept trophic factors delivered by the tumor stroma is now available for cancer therapy. These mAbs can exert direct antiproliferative/cytotoxic effects as they inhibit pro-survival signal transduction...
Na minha lista:
Foilsithe in: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
Taylor & Francis
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4368132/ https://ncbi.nlm.nih.gov/pubmed/25949870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.985940 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|